News & Analysis as of

Food and Drug Administration (FDA) › Health Care Providers › Medical Supplies

McDermott Will & Emery

FDA Gives Companies a New Way to Fight Misinformation

McDermott Will & Emery on

Misinformation shared by independent third parties presents a significant public health concern because it can lead patients and healthcare providers to forgo treatments that are safe and effective or choose treatments that...more

Foley & Lardner LLP

FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products

Foley & Lardner LLP on

On October 23, the U.S. Food and Drug Administration (FDA) issued draft guidance, Communication from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products on...more

Alston & Bird

Alston & Bird Health Care Week in Review - January 2022 #2

Alston & Bird on

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

Alston & Bird

COVID-19 Medical Products Supply Chain Week in Review – May 2021 #4

Alston & Bird on

In the past week, President Biden revealed a new plan to share COVID-19 vaccines with other countries, and the CDC allowed vaccination sites to prioritize vaccinations over minimizing waste; both actions reflect the...more

Womble Bond Dickinson

Emergency Use Authorization Issued for COVID-19 Antibody

Womble Bond Dickinson on

On November, 10, 2020, the US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for the investigational neutralizing antibody bamlanivimab (Eli Lilly and Company, Indianapolis, IN) for the...more

Mintz - Health Care Viewpoints

FDA Continues Its Diverse Agency Actions in Response to COVID-19 Pandemic

Mintz - Health Care Viewpoints on

Since our last roundup-style blog post on the response of the Food and Drug Administration (FDA) to the COVID-19 public health emergency, the agency has taken a wide variety of additional actions with the goal of getting...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide